Volume 11; Issue 3 & 4

Main
Behavioural Pharmacology
Volume 11; Issue 3 & 4

Behavioural Pharmacology

Volume 11; Issue 3 & 4

1

Pharmacological and molecular targets in the search for novel antipsychotics

Scatton, B., Sanger, D.J.

Journal:

Behavioural Pharmacology

Année:

2000

Langue:

english

Fichier:

PDF, 215 KB

english, 2000

2

Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon

Swerdlow, N.R., Braff, D.L., Geyer, M.A.

Journal:

Behavioural Pharmacology

Année:

2000

Langue:

english

Fichier:

PDF, 3.84 MB

english, 2000

3

Exaggerated MK-801-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus

Al-Amin, H.A., Weinberger, D.R., Lipska, B.K.

Journal:

Behavioural Pharmacology

Année:

2000

Langue:

english

Fichier:

PDF, 6.24 MB

english, 2000

4

Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice

Spielewoy, C., Roubert, C., Hamon, M., Nosten, M., Betancur, C., Giros, B.

Journal:

Behavioural Pharmacology

Année:

2000

Langue:

english

Fichier:

PDF, 10.97 MB

english, 2000

5

Can animal models help to understand human diseases? Commentary on Swerdlow et al., ‘Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon’

Journal:

Behavioural Pharmacology

Année:

2000

Langue:

english

Fichier:

PDF, 109 KB

english, 2000

6

In-vivo assessment of 5-HT2A and 5-HT2C antagonistic properties of newer antipsychotics

Sánchez, C., Arnt, J.

Journal:

Behavioural Pharmacology

Année:

2000

Langue:

english

Fichier:

PDF, 3.75 MB

english, 2000

7

Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy

Prinssen, E.P.M., Koek, W., Colpaert, F.C., Kleven, M.S.

Journal:

Behavioural Pharmacology

Année:

2000

Langue:

english

Fichier:

PDF, 2.12 MB

english, 2000

8

Animal models for the negative symptoms of schizophrenia

Ellenbroek, B.A., Cools, A.R.

Journal:

Behavioural Pharmacology

Année:

2000

Langue:

english

Fichier:

PDF, 160 KB

english, 2000

9

Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia

Le Pen, G., Grottick, A.J., Higgins, G.A., Martin, J.R., Jenck, F., Moreau, J.-L.

Journal:

Behavioural Pharmacology

Année:

2000

Langue:

english

Fichier:

PDF, 6.08 MB

english, 2000

10

Context determines the type of sensitized behaviour: a brief review and a hypothesis on the role of environment in behavioural sensitization

Ohmori, T., Abekawa, T., Ito, K., Koyama, T.

Journal:

Behavioural Pharmacology

Année:

2000

Langue:

english

Fichier:

PDF, 158 KB

english, 2000

11

Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D2-receptor occupancy

Oades, R.D., Rao, M.L., Bender, S., Sartory, G., Müller, B.W.

Journal:

Behavioural Pharmacology

Année:

2000

Langue:

english

Fichier:

PDF, 4.06 MB

english, 2000

12

A human perspective:Commentary on Swerdlow et al., ‘Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon’

Journal:

Behavioural Pharmacology

Année:

2000

Langue:

english

Fichier:

PDF, 103 KB

english, 2000

13

Low-dose clozapine pretreatment partially prevents haloperidol-induced deficits in conditioned active avoidance

Murphy, C.A., Feldon, J.

Journal:

Behavioural Pharmacology

Année:

2000

Langue:

english

Fichier:

PDF, 6.50 MB

english, 2000

14

Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders

Aloe, L., Iannitelli, A., Angelucci, F., Bersani, G., Fiore, M.

Journal:

Behavioural Pharmacology

Année:

2000

Langue:

english

Fichier:

PDF, 1.40 MB

english, 2000